In light of that, a natural compound like RSV, which might increase the RXR gene expression and decrease IL-17A, IL-17F and IL-19 gene expression in psoriasis-affected skin, could be an interesting new treatment modality in human clinical trials. The gene discussed is IL19; the disease is psoriasis.